Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts

INTRODUCTION: Buruli ulcer (BU) is an infectious skin disease, caused by Mycobacterium ulcerans, endemic in more than 30 countries worldwide especially Africa. Brong-Ahafo Region implemented WHO recommended daily treatment with streptomycin and rifampicin for eight weeks (SR8). Yet limited assessmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pan Afr Med J
Main Authors: Iddrisah, Florence Nzilanye, Yeboah-Manu, Dorothy, Nortey, Pricillia Awoh, Nyarko, Kofi Mensah, Anim, Jones, Antara, Simon Nyovuura, Kenu, Ernest, Wurapa, Fred, Afari, Edwin Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: The African Field Epidemiology Network 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5257010/
https://ncbi.nlm.nih.gov/pubmed/28149438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11604/pamj.supp.2016.25.1.6203
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados